Chavan C, Ray S, Kumar C
Indian J Med Res. 2024; 160(5):411-427.
PMID: 39737504
PMC: 11683502.
DOI: 10.25259/ijmr_2141_23.
Mathews D, Abernethy A, Chaikof E, Charo R, Daley G, Enriquez J
NAM Perspect. 2024; 2023.
PMID: 38855738
PMC: 11157685.
DOI: 10.31478/202311d.
Villegas-Valverde C, Bencomo-Hernandez A, Castillo-Aleman Y, Ventura-Carmenate Y, Casado-Hernandez I, Rivero-Jimenez R
Hematol Transfus Cell Ther. 2024; 46 Suppl 6:S59-S70.
PMID: 38177056
PMC: 11726105.
DOI: 10.1016/j.htct.2023.10.008.
Sharma N, Choudhary B
Biomolecules. 2023; 13(11).
PMID: 38002311
PMC: 10669790.
DOI: 10.3390/biom13111629.
Ates O, Uh J, Pirlepesov F, Hua C, Triplett B, Qudeimat A
Cancers (Basel). 2023; 15(21).
PMID: 37958335
PMC: 10650483.
DOI: 10.3390/cancers15215161.
Unedited allogeneic iNKT cells show extended persistence in MHC-mismatched canine recipients.
Rotolo A, Whelan E, Atherton M, Kulikovskaya I, Jarocha D, Fraietta J
Cell Rep Med. 2023; 4(10):101241.
PMID: 37852175
PMC: 10591065.
DOI: 10.1016/j.xcrm.2023.101241.
Hematopoietic stem cell transplantation in Zagreb: the first 40 years.
Labar B
Croat Med J. 2023; 64(2):123-134.
PMID: 37131314
PMC: 10183962.
Milestones in acute GVHD pathophysiology.
Socie G, Michonneau D
Front Immunol. 2022; 13:1079708.
PMID: 36544776
PMC: 9760667.
DOI: 10.3389/fimmu.2022.1079708.
Cardiovascular disease and chimeric antigen receptor cellular therapy.
Rao A, Stewart A, Eljalby M, Ramakrishnan P, Anderson Jr L, Awan F
Front Cardiovasc Med. 2022; 9:932347.
PMID: 36211558
PMC: 9538377.
DOI: 10.3389/fcvm.2022.932347.
Treatment planning of total marrow irradiation with intensity-modulated spot-scanning proton therapy.
Zuro D, Vidal G, Cantrell J, Chen Y, Han C, Henson C
Front Oncol. 2022; 12:955004.
PMID: 35965505
PMC: 9365973.
DOI: 10.3389/fonc.2022.955004.
Genome Editing in Medicine: Tools and Challenges.
Petraityte G, Preiksaitiene E, Mikstiene V
Acta Med Litu. 2022; 28(2):205-219.
PMID: 35637939
PMC: 9133615.
DOI: 10.15388/Amed.2021.28.2.8.
Advances in Allogeneic Cancer Cell Therapy and Future Perspectives on "Off-the-Shelf" T Cell Therapy Using iPSC Technology and Gene Editing.
Furukawa Y, Hamano Y, Shirane S, Kinoshita S, Azusawa Y, Ando J
Cells. 2022; 11(2).
PMID: 35053386
PMC: 8773622.
DOI: 10.3390/cells11020269.
Total Body Irradiation Forever? Optimising Chemotherapeutic Options for Irradiation-Free Conditioning for Paediatric Acute Lymphoblastic Leukaemia.
Ben Hassine K, Powys M, Svec P, Pozdechova M, Versluys B, Ansari M
Front Pediatr. 2021; 9:775485.
PMID: 34956984
PMC: 8705537.
DOI: 10.3389/fped.2021.775485.
Therapeutic Potential of Mesenchymal Stromal Cells and Extracellular Vesicles in the Treatment of Radiation Lesions-A Review.
Rezvani M
Cells. 2021; 10(2).
PMID: 33670501
PMC: 7922519.
DOI: 10.3390/cells10020427.
Implications of hematopoietic stem cells heterogeneity for gene therapies.
Epah J, Schafer R
Gene Ther. 2021; 28(9):528-541.
PMID: 33589780
PMC: 8455331.
DOI: 10.1038/s41434-021-00229-x.
Total marrow irradiation for hematopoietic malignancies using volumetric modulated arc therapy: A review of treatment planning studies.
Mancosu P, Cozzi L, Paul Muren L
Phys Imaging Radiat Oncol. 2021; 11:47-53.
PMID: 33458277
PMC: 7807866.
DOI: 10.1016/j.phro.2019.08.001.
Organ sparing of linac-based targeted marrow irradiation over total body irradiation.
Warrell G, Colussi V, Swanson W, Caimi P, Mansur D, De Lima M
J Appl Clin Med Phys. 2019; 20(11):69-79.
PMID: 31605462
PMC: 6839384.
DOI: 10.1002/acm2.12742.
Ethical development of stem-cell-based interventions.
Macpherson A, Kimmelman J
Nat Med. 2019; 25(7):1037-1044.
PMID: 31270501
DOI: 10.1038/s41591-019-0511-6.
New insights into hematopoietic differentiation landscapes from single-cell RNA sequencing.
Watcham S, Kucinski I, Gottgens B
Blood. 2019; 133(13):1415-1426.
PMID: 30728144
PMC: 6440294.
DOI: 10.1182/blood-2018-08-835355.
Cancer immunotherapy with CAR-T cells - behold the future.
Graham C, Hewitson R, Pagliuca A, Benjamin R
Clin Med (Lond). 2018; 18(4):324-328.
PMID: 30072559
PMC: 6334043.
DOI: 10.7861/clinmedicine.18-4-324.
